SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

Signal Transduct Target Ther. 2022 Jan 24;7(1):22. doi: 10.1038/s41392-022-00878-3.

Abstract

As a highly pathogenic human coronavirus, SARS-CoV-2 has to counteract an intricate network of antiviral host responses to establish infection and spread. The nucleic acid-induced stress response is an essential component of antiviral defense and is closely related to antiviral innate immunity. However, whether SARS-CoV-2 regulates the stress response pathway to achieve immune evasion remains elusive. In this study, SARS-CoV-2 NSP5 and N protein were found to attenuate antiviral stress granule (avSG) formation. Moreover, NSP5 and N suppressed IFN expression induced by infection of Sendai virus or transfection of a synthetic mimic of dsRNA, poly (I:C), inhibiting TBK1 and IRF3 phosphorylation, and restraining the nuclear translocalization of IRF3. Furthermore, HEK293T cells with ectopic expression of NSP5 or N protein were less resistant to vesicular stomatitis virus infection. Mechanistically, NSP5 suppressed avSG formation and disrupted RIG-I-MAVS complex to attenuate the RIG-I-mediated antiviral immunity. In contrast to the multiple targets of NSP5, the N protein specifically targeted cofactors upstream of RIG-I. The N protein interacted with G3BP1 to prevent avSG formation and to keep the cofactors G3BP1 and PACT from activating RIG-I. Additionally, the N protein also affected the recognition of dsRNA by RIG-I. This study revealed the intimate correlation between SARS-CoV-2, the stress response, and innate antiviral immunity, shedding light on the pathogenic mechanism of COVID-19.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorocebus aethiops
  • Coronavirus 3C Proteases / genetics*
  • Coronavirus 3C Proteases / immunology
  • Coronavirus Nucleocapsid Proteins / genetics*
  • Coronavirus Nucleocapsid Proteins / immunology
  • DEAD Box Protein 58 / genetics*
  • DEAD Box Protein 58 / immunology
  • DNA Helicases / genetics*
  • DNA Helicases / immunology
  • Gene Expression Regulation
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Immune Evasion
  • Phosphoproteins / genetics
  • Phosphoproteins / immunology
  • Poly I-C / pharmacology
  • Poly-ADP-Ribose Binding Proteins / genetics*
  • Poly-ADP-Ribose Binding Proteins / immunology
  • Protein Binding
  • RNA Helicases / genetics*
  • RNA Helicases / immunology
  • RNA Recognition Motif Proteins / genetics*
  • RNA Recognition Motif Proteins / immunology
  • RNA, Double-Stranded / genetics
  • RNA, Double-Stranded / immunology
  • RNA-Binding Proteins / genetics*
  • RNA-Binding Proteins / immunology
  • Receptors, Immunologic / genetics*
  • Receptors, Immunologic / immunology
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity
  • Sendai virus / genetics
  • Sendai virus / immunology
  • Signal Transduction
  • Stress Granules / drug effects
  • Stress Granules / genetics*
  • Stress Granules / immunology
  • Stress Granules / virology
  • Vero Cells
  • Vesiculovirus / genetics
  • Vesiculovirus / immunology

Substances

  • Coronavirus Nucleocapsid Proteins
  • PRKRA protein, human
  • Phosphoproteins
  • Poly-ADP-Ribose Binding Proteins
  • RNA Recognition Motif Proteins
  • RNA, Double-Stranded
  • RNA-Binding Proteins
  • Receptors, Immunologic
  • nucleocapsid phosphoprotein, SARS-CoV-2
  • 3C-like proteinase, SARS-CoV-2
  • Coronavirus 3C Proteases
  • RIGI protein, human
  • DNA Helicases
  • G3BP1 protein, human
  • DEAD Box Protein 58
  • RNA Helicases
  • Poly I-C